Sun Pharma Demands Generic Cancer Drug Market Exclusivity
Sun Pharmaceutical Industries Ltd. urged a District of Columbia federal judge Friday to block the U.S. Food and Drug Administration from approving any generic versions of the oncology drug Zometa until...To view the full article, register now.
Already a subscriber? Click here to view full article